Welcome to our dedicated page for PROGRESSIVE CARE news (Ticker: RXMD), a resource for investors and traders seeking the latest updates and insights on PROGRESSIVE CARE stock.
Progressive Care, Inc., through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization providing administration, practice management, tele-pharmco, utilization management, quality assurance, EHR implementation, billing and coding, health practice risk management, prescription pharmaceuticals, compounded medications, anti-retroviral medications, MTM, and prescription medications to long-term care facilities.
Progressive Care Inc. (OTCQB: RXMD) reported its financial results for the year ending December 31, 2022, showing a 5% revenue increase to $40.6 million. Key highlights include a 7% rise in prescription revenue to $36.3 million and a $1.0 million increase in 340B contract revenue. However, gross profit margin decreased from 26% to 24%, primarily due to reduced COVID-19 testing revenue. The net loss expanded to $5.9 million, influenced by non-recurring expenses. The company successfully raised $5.4 million in capital and reduced convertible debt interest rates from 10% to 5%.